Chinese Japanese Germany Korea

(1S,4bα,7E,8aβ,10aα)-Tetradecahydro-9β-hydroxy-7-[[N-(2-hydroxyethyl)-N-methylcarbamoyl]methylene]-1,4aβ,8α-trimethyl-10-oxophenanthrene-1β-carboxylic acid methyl ester

(1S,4bα,7E,8aβ,10aα)-Tetradecahydro-9β-hydroxy-7-[[N-(2-hydroxyethyl)-N-methylcarbamoyl]methylene]-1,4aβ,8α-trimethyl-10-oxophenanthrene-1β-carboxylic acid methyl ester Structure
(1S,4bα,7E,8aβ,10aα)-Tetradecahydro-9β-hydroxy-7-[[N-(2-hydroxyethyl)-N-methylcarbamoyl]methylene]-1,4aβ,8α-trimethyl-10-oxophenanthrene-1β-carboxylic acid methyl ester structure
CAS No.
41758-72-9
Chemical Name:
(1S,4bα,7E,8aβ,10aα)-Tetradecahydro-9β-hydroxy-7-[[N-(2-hydroxyethyl)-N-methylcarbamoyl]methylene]-1,4aβ,8α-trimethyl-10-oxophenanthrene-1β-carboxylic acid methyl ester
Synonyms
Norerythrosuamide;(1S,4bα,7E,8aβ,10aα)-Tetradecahydro-9β-hydroxy-7-[[N-(2-hydroxyethyl)-N-methylcarbamoyl]methylene]-1,4aβ,8α-trimethyl-10-oxophenanthrene-1β-carboxylic acid methyl ester;1-Phenanthrenecarboxylic acid, tetradecahydro-9-hydroxy-7-[2-[(2-hydroxyethyl)methylamino]-2-oxoethylidene]-1,4a,8-trimethyl-10-oxo-, methyl ester, (1S,4aR,4bS,7E,8R,8aS,9R,10aR)-
CBNumber:
CB62430380
Molecular Formula:
C24H37NO6
Molecular Weight:
435.55368
MDL Number:
MOL File:
41758-72-9.mol
Last updated:2023-07-14 17:39:16
Request For Quotation

(1S,4bα,7E,8aβ,10aα)-Tetradecahydro-9β-hydroxy-7-[[N-(2-hydroxyethyl)-N-methylcarbamoyl]methylene]-1,4aβ,8α-trimethyl-10-oxophenanthrene-1β-carboxylic acid methyl ester Properties

Melting point 86-88 °C
Boiling point 614.9±55.0 °C(Predicted)
Density 1.198±0.06 g/cm3(Predicted)
pka 12.48±0.70(Predicted)

(1S,4bα,7E,8aβ,10aα)-Tetradecahydro-9β-hydroxy-7-[[N-(2-hydroxyethyl)-N-methylcarbamoyl]methylene]-1,4aβ,8α-trimethyl-10-oxophenanthrene-1β-carboxylic acid methyl ester Chemical Properties,Uses,Production

Description

Norerythrosuamide accompanies norcoumingide (q.v.) in the bark extract of Erythrophleum couminga and may be separated from the latter base by chromatographic methods. The structure is based upon chemical analysis and spectroscopic evidence.

References

Cronlund, Okagawa, Acta Pharm. Suec., 12,467 (1975)

(1S,4bα,7E,8aβ,10aα)-Tetradecahydro-9β-hydroxy-7-[[N-(2-hydroxyethyl)-N-methylcarbamoyl]methylene]-1,4aβ,8α-trimethyl-10-oxophenanthrene-1β-carboxylic acid methyl ester Preparation Products And Raw materials

Raw materials

Preparation Products

(1S,4bα,7E,8aβ,10aα)-Tetradecahydro-9β-hydroxy-7-[[N-(2-hydroxyethyl)-N-methylcarbamoyl]methylene]-1,4aβ,8α-trimethyl-10-oxophenanthrene-1β-carboxylic acid methyl ester Norerythrosuamide 1-Phenanthrenecarboxylic acid, tetradecahydro-9-hydroxy-7-[2-[(2-hydroxyethyl)methylamino]-2-oxoethylidene]-1,4a,8-trimethyl-10-oxo-, methyl ester, (1S,4aR,4bS,7E,8R,8aS,9R,10aR)- 41758-72-9